Amanote Research
Register
Sign In
An Estrogen Receptor-Negative Breast Cancer Subset Characterized by a Hormonally Regulated Transcriptional Program and Response to Androgen
Oncogene
- United Kingdom
doi 10.1038/sj.onc.1209415
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Genetics
Molecular Biology
Date
February 20, 2006
Authors
A S Doane
M Danso
P Lal
M Donaton
L Zhang
C Hudis
W L Gerald
Publisher
Springer Science and Business Media LLC
Related search
How to Target Estrogen Receptor-Negative Breast Cancer?
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Androgen Receptor-Positive, Triple-Negative Breast Cancer
Cancer
Cancer Research
Oncology
Reversal of the Estrogen Receptor Negative Phenotype in Breast Cancer and Restoration of Antiestrogen Response
Clinical Cancer Research
Cancer Research
Oncology
Estrogen Receptor-Negative Breast Cancer: New Insights Into Subclassification and Targeting
Clinical Cancer Research
Cancer Research
Oncology
Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer
International Journal of Cancer
Cancer Research
Oncology
Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison
Human Pathology
Forensic Medicine
Pathology
Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment
Oncotarget
Oncology
Selected Estrogen Receptor 1 and Androgen Receptor Gene Polymorphisms in Relation to Risk of Breast Cancer and Fibrocystic Breast Conditions Among Chinese Women
Cancer Epidemiology
Cancer Research
Epidemiology
Oncology
Expression of Androgen Receptor and C-Kit (CD117) in Triple Negative Breast Cancer
Immunopathology, Allergology, Infectology
